News
Canadian Institutes of Health Research funds five research projects at IRIC
Published on February 14, 2025
The Canadian Institutes of Health Research (CIHR) recently awarded Project Grants for the Fall 2024 competition. This program aims to support original ideas with the potential to advance basic and applied health knowledge.
Across the country, 453 research projects were funded, representing a total investment of $411 million. Five projects involving IRIC teams are recipients of these prestigious grants.
Congratulations to our teams!
- Geneviève Deblois, Director of the Metabolic and Epigenetic Alterations in Cancer Research Unit, is co-investigator on the “Targeting drug tolerant persister cells in poor outcome breast cancer” project, led by Morag Park of the Goodman Cancer Institute and financed to the extent of $1,136,025 over 5 years.
- Jean-Claude Labbé, Director of the Cell Division and Differentiation Research Unit, together with McGill University researcher Abigail Gerhold, has been awarded $979,200 over five years for the project “Regulating spindle orientation to drive tissue shape and elongation during C. elegans gonad development”.
- Philippe Roux, Director of the Cell Signaling and Proteomics Research Unit, in collaboration with Université Laval researcher Jean-Philippe Lambert, has been awarded $1,193,400 in funding over five years for the project “Regulation of BRD2 phosphorylation and its role in melanoma progression”.
- Marc Therrien, Director of the Intracellular Signalling Research Unit, was awarded a 5-year grant of $1,081,981 for his project “Characterization of human CNK and KSR proteins in cancer cell motility”.
- Marc Therrien was awarded a second Project grant of $875,925 for 5 years, for the project “Structure-function analysis of RAF-containing complexes”.
